financetom
Business
financetom
/
Business
/
China Evergrande's liquidators still in talks for stake sale in EV unit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China Evergrande's liquidators still in talks for stake sale in EV unit
Oct 2, 2024 11:59 PM

(Reuters) - (This Sept. 26 story has been corrected to remove the incorrect references to liquidators of China Evergrande New Energy Vehicle Group as they are related to parent company China Evergrande Group, in paragraphs 1 and 3)

Liquidators of debt-laden China Evergrande are still in talks with a potential buyer to sell a stake in the electric vehicle arm of the company with a view to provide a new credit line to support production.

In its initial days, the electric vehicle (EV) maker aimed to take on Tesla and had a market valuation higher than Ford Motor, but it has since been mired in the debt crisis engulfing its property developer parent.

China Evergrande New Energy Vehicle said on Thursday liquidators of its parent company China Evergrande had not yet entered an agreement with any potential stake buyer nor has there been any deal to extend credit to the electric vehicle manufacturer.

The non-binding deal put-forth by China Evergrande Group liquidators provides for a third-party buyer to take a stake of 29% in the unit, with an option for 29.5% more, the EV arm had said in a statement in late May.

The EV maker, which in August said two of its units had commenced bankruptcy proceedings, has been severely short of funds and has faced pressure from its creditors and a local government.

(Reporting by Rishav Chatterjee in Bengaluru; Editing by Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Union Pacific, Norfolk shareholders approve $85 billion merger
Union Pacific, Norfolk shareholders approve $85 billion merger
Nov 14, 2025
(Reuters) -Union Pacific and Norfolk Southern ( NSC ) shareholders approved a deal to merge both railroad operators, the companies said on Friday. Over 99% of shareholders at both Union Pacific and Norfolk voted in favor of the $85 billion deal. The deal, which has drawn a positive response from U.S. President Donald Trump, is still subject to regulatory clearance...
US drops Biden plan to require passenger compensation for delayed flights
US drops Biden plan to require passenger compensation for delayed flights
Nov 14, 2025
WASHINGTON (Reuters) -President Donald Trump's administration said on Friday it was formally withdrawing a plan by his predecessor to require airlines to pay passengers cash compensation when U.S. flight disruptions are caused by carriers. In December 2024, the U.S. Transportation Department under then-President Joe Biden sought public comment on writing rules to require airlines to pay $200 to $300 for...
E-commerce services provider iPower Q1 loss narrows on cost cuts, revenue drops
E-commerce services provider iPower Q1 loss narrows on cost cuts, revenue drops
Nov 14, 2025
Overview * iPower fiscal Q1 2026 revenue fell to $12 mln from $19 mln year-over-year * Net loss improved to $0.5 mln from $2.1 mln in fiscal Q1 2025 * Total debt reduced by 48% to $1.9 mln as of September 30, 2025 Outlook * iPower focuses on building a more efficient and profitable organization * iPower enhances supply chain...
Tempus AI Partners With IFLI Over New Research Study on Follicular Lymphoma
Tempus AI Partners With IFLI Over New Research Study on Follicular Lymphoma
Nov 14, 2025
09:27 AM EST, 11/14/2025 (MT Newswires) -- Tempus AI ( TEM ) said Friday it is commencing a new follicular lymphoma research study in partnership with the Institute for Follicular Lymphoma Innovation. The multi-year study will enroll participants to generate a multi-omic dataset to support research regarding precision medicine and biomarker discovery in follicular lymphoma, the company said. Tempus' stock...
Copyright 2023-2026 - www.financetom.com All Rights Reserved